Ahmet, M.T., et al., “A Potential Iron Pharmaceutical Composition for the Treatment of Iron-deficiency Anaemia. The Crystal and Molecular Structure of mer-Tris-(3-hydroxy-2-methyl-4H-pyran-4-onato) iron (III),” J. Chem. Soc. Dalton Trans. 1159-1163, Royal Society of Chemistry (1988). |
El-Jammal, A. and Templeton, D.M., “Reversed-phase high-performance liquid chromatography of non-transferrin-bound iron and some hydroxypyridone and hydroxypyrone chelators,” J. Chromatography B. 658:121-127, Elsevier Science (Aug. 1994). |
Luca, C., et al., “The Amphionic Structure of 3-Hydroxy-2-methyl-4H-pyran-4-one and the Properties of its Complexes with Iron Ions,” Rev. Roum. Chim. 38:123-130, Acadéémie de la Republique Populaire Roumaine (1993). |
Rice-Evans, C. and Baysal, E., “Iron-mediated oxidative stress in erythrocytes,” Biochem. J. 244:191-196, Portland Press on Behalf of the Biochemical Society (1987). |
Seeberg, H.P., et al., “Hemoglobin Regeneration Following Oral Administration of Chelated Iron,” Science 119:608-609, American Association for the Advancement of Science (1954). |
Stevanović, A., et al., “On the Reaction of Iron(III) with Maltol,” Collection Czechoslov. Chem. Commun. 33:4198-4214, Nakladatelstvi Ceskoslovenski Akademie Ved (1968). |
English language abstract of Japanese Patent No. 03 067 565, Dialog File 351, Derwent WPI Accession No. 91-128755 (1991). |
English language abstract of Hoiman, J.M., et al., “Spectrophotometric study of the iron-meconic acid complexes,” Glas. Hem. Drus., Beograd 31:311-311-324, (1966), Dialog File 399 (Chemical Abstracts) Accession No. 70:51157 CA, Chemical Abstracts Service (1970). |
International Search Report for International Application No. PCT/GB96/01382, issued Jan. 30, 1997. |
International Search Report for International Application No. PCT/GB01/04052, mailed Dec. 2, 2002. |